[Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
D000019:Abortifacient Agents; D000028:Abortion, Induced / Q000379:methods; D000030:Abortion, Missed / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D015232:Dinoprostone / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage / Q000627:therapeutic use*
D000019:Abortifacient Agents; D011459:Prostaglandins E, Synthetic; C016767:sulprostone; D015232:Dinoprostone
L'uso di una nuova prostaglandina di sintesi (sulprostone) in diverse condizioni ostetriche.